Professor, Psychiatry, UCLA School of Medicine
Psychiatry
Dr. James J. McGough, MD
|
|
Give Review
James McGough practices Psychiatry. He studied medicine at Duke University School of Medicine. Duke University School of Medicine is a top medical college. Duke University School of Medicine is ranked 8 in research and 29 in primary care medicine He received 3 awards: "Top Doctors:LA Area", "Top Doctors:Southern California" and "Super Doctor". Dr. James J. McGough is a published physician. He published 99 publications, including: 'Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder.' He is registered with Medicare.
Publications
- An Eight-week, Open-trial, Pilot Feasibility Study of Trigeminal Nerve Stimulation in Youth With Attention-deficit/Hyperactivity Disorder.
- Sofinicline : a novel nicotinic acetylcholine receptor agonist in the treatment of Attention-deficit/hyperactivity disorder.
- Neurophysiologic predictors of response to atomoxetine in young adults with Attention deficit hyperactivity disorder: A pilot project.
- Neural activation during response inhibition in adult Attention-deficit/hyperactivity disorder: Preliminary findings on the effects of medication and symptom severity.
- Electroencephalography correlates of spatial working memory deficits in Attention-deficit/hyperactivity disorder: vigilance, encoding, and maintenance.
- A potential electroencephalography and cognitive biosignature for the child behavior checklist-dysregulation profile.
- Characterization of the theta to beta ratio in ADHD: identifying potential sources of heterogeneity.
- The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.
- A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD.
- Atomoxetine treatment of Attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlle...
- ADHD comorbidity can matter when assessing cortical thickness abnormalities in patients with bipolar Disorder.
- Frontostriatal neuroimaging findings differ in patients with bipolar Disorder who have or do not have ADHD comorbidity.
- Genome-wide association study of intelligence: additive effects of novel brain expressed genes.
- Sex subgroup analysis of treatment response to lisdexamfetamine dimesylate in children aged 6 to 12 years with Attention-deficit/hyperactivity disorder.
- Characteristics and comorbidity of ADHD sib pairs in the Central Valley of Costa Rica.
- Hats off: 2010 Journal awards.
- Familial clustering and DRD4 effects on electroencephalogram measures in multiplex families with Attention deficit/hyperactivity disorder.
- Mixed-handedness is linked to mental health problems in children and adolescents.
- A candidate gene analysis of methylphenidate response in Attention-deficit/hyperactivity disorder.
- Estimating the size of treatment effects: moving beyond p values.
- Long-term safety and efficacy of guanfacine extended release in children and adolescents with Attention-deficit/hyperactivity disorder.
- Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD.
- Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress Disorder.
- Genome-wide association study of response to methylphenidate in 187 children with Attention-deficit/hyperactivity disorder.
- Meta-analysis of genome-wide linkage scans of Attention deficit hyperactivity disorder.
- CBCL pediatric bipolar Disorder profile and ADHD: comorbidity and quantitative trait loci analysis.
- Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study.
- Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with Attention-deficit/hyperactivity disorder.
- The pharmacogenomic era: promise for personalizing Attention deficit hyperactivity disorder therapy.
- Diagnosing and managing complicated ADHD.
- Prevalence and psychiatric comorbidity of Attention-deficit/hyperactivity disorder in an adolescent Finnish population.
- Subtypes versus severity differences in Attention-deficit/hyperactivity disorder in the Northern Finnish Birth Cohort.
- Executive functioning among Finnish adolescents with Attention-deficit/hyperactivity disorder.
- ADHD symptoms and subtypes: relationship between childhood and adolescent symptoms.
- ADHD candidate gene study in a population-based birth cohort: association with DBH and DRD2.
- Clinical presentation of Attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study...
- Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
- Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
- Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
- Parent versus teacher ratings of Attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (P...
- Factor structure of parent- and teacher-rated Attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treat...
- Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
- Atypical brain activation during simple & complex levels of processing in adult ADHD: an fMRI study.
- Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with Attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, dou...
- Adult Attention deficit hyperactivity disorder: moving beyond DSM-IV.
- Once-daily OROS methylphenidate is safe and well tolerated in adolescents with Attention-deficit/hyperactivity disorder.
- Relationship of family environment and parental psychiatric diagnosis to impairment in ADHD.
- A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxeti...
- Pharmacological management of preschool ADHD.
- Psychiatric comorbidity in adult Attention deficit hyperactivity disorder: findings from multiplex families.
- Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.
- Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
- Attention-deficit/hyperactivity disorder pharmacogenomics.
- Temperament and character profiles and the dopamine D4 receptor gene in ADHD.
- Diagnostic controversies in adult Attention deficit hyperactivity disorder.
- Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11.
- Second-generation antipsychotic medications in children and adolescents.
- Maternal smoking and Hyperactivity in 8-year-old children.
- Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.
- Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.
- A genomewide scan for Attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11.
- Genetic linkage of Attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism.
- A genomewide scan for loci involved in Attention-deficit/hyperactivity disorder.
- Genome-wide association study of proneness to anger.
- Predictors of accidental fatal drug overdose among a cohort of injection drug users.
- Genome-wide association study of the child behavior checklist dysregulation profile.
- Utility of the SCL-90-R with depressed and conduct-Disordered adolescent inpatients.
- ADHD and comorbid Disorders in relation to family environment and symptom severity.
- Children''s Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental Disorders.
- Safety and tolerability of methylphenidate in preschool children with ADHD.
- Pharmacogenetics of methylphenidate response in preschoolers with ADHD.
- Acute and long-term safety and tolerability of risperidone in children with autism.
- No evidence of linkage or linkage disequilibrium between DAT1 and Attention deficit hyperactivity disorder in a large sample.
- Multisite controlled study of OROS methylphenidate in the treatment of adolescents with Attention-deficit/hyperactivity disorder.
- Meta-analysis of genome-wide association studies of Attention-deficit/hyperactivity disorder.
- Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.
- Stimulant-related reductions of growth rates in the PATS.
- Refining the ADHD phenotype using affected sibling pair families.
- Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).
- Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and Anxiety disorders.
- Family-based genome-wide association scan of Attention-deficit/hyperactivity disorder.
- Mindfulness and Attention deficit hyperactivity disorder.
- Cognitive functioning in affected sibling pairs with ADHD: familial clustering and dopamine genes.
- Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
- Guanfacine extended release in children and adolescents with Attention-deficit/hyperactivity disorder: a placebo-controlled trial.
- Biased paternal transmission of SNAP-25 risk alleles in Attention-deficit hyperactivity disorder.
- Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with Attention deficit hyperactivity disorder (ADHD).
- Familial clustering of symptoms and disruptive behaviors in multiplex families with Attention-deficit/hyperactivity disorder.
- Assessment of Attention deficit hyperactivity disorder: a review of recent literature.
- Assessment in multisite randomized clinical trials of patients with autistic Disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology.
- Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
- Evidence that the dopamine D4 receptor is a susceptibility gene in Attention deficit hyperactivity disorder.
- ECT in children and adolescents.
- Management of the agitated patient. A pharmacological update.
- Attention deficit hyperactivity disorder.
- Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
- Genome-wide scan of reading ability in affected sibling pairs with Attention-deficit/hyperactivity disorder: unique and shared genetic effects.
- MethyPatch Noven.
Schools
Duke University
Duke University Med Center
UCLA Neuropsych Hospital
Procedures Preformed
- Psychiatric Evaluation
Conditions Treated
- Anxiety
- Attention Deficit Hyperactivity Disorder (ADHD)
- Major Depressive Disorder
- Phobia
- View All
Doctors Specialties
- Addiction Psychiatry
- Psychiatry
Accepted Insurances
Awards
- Top Doctors:LA Area
- Top Doctors:Southern California
- Super Doctor
Education
-
UCLA Neuropsychiatric Hospital -
Duke University Hospital -
Duke University School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Neil B. Haas, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David T. Feinberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen A. Miotto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip D. Kanof, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mehrdad Jalali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Behnaz Jalali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander Fan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James E. Luzano, MD |
|
|
Dr. Roderick E. Shaner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arash Jobrani-Farzaneh-Far, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John O. Schairer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Megan D. Johnson, MD |